๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.
NCT07152340Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital
Phase 4
64
Changhua, Shanghai
2025-04-10
Not yet open
A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery
NCT06828419Adenopathy, Uterine Fibroids, Ovarian Cysts, Adnexal Mass
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
63
Wenzhou
2025-04-10
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
NCT06868277Carcinoma, Non-Small Cell Lung
AstraZeneca
Phase 3
830
Baoding, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou
2025-04-10
Recruiting
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
NCT06937112Lung Cancers, Pancreatic Cancer, Neuroendocrine Tumors, Thyroid Cancer
Nanjing First Hospital, Nanjing Medical University
Observational
20
Nanjing
2025-04-10
Recruiting
Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer
NCT06916637Breast Cancer, Breast Cancer, HER2-Expression
The Affiliated Hospital of Qingdao University
Observational
40
Qingdao
2025-04-09
Recruiting
Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma
NCT06956716Advanced Intrahepatic Cholangiocarcinoma
Zhejiang University
Phase 1/2
30
Hangzhou
2025-04-09
Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
NCT06790693Breast Cancer
Hoffmann-La Roche
Phase 3
450
Xiangyang, Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Jiangmen
2025-04-09
Recruiting
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
NCT06822790Hypertriglyceridemia
Arrowhead Pharmaceuticals
Phase 3
869
Bengbu, Beijing, Guangzhou, Liuzhou, Xingtai, Luoyang, Changsha, Wuhan
2025-04-09
Recruiting
Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease
NCT06793475Extramedullary Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
20
Beijing, Tianjin
2025-04-09
By invitation
To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia
NCT07123402Chronic Postoperative Neuralgia
Beijing Tide Pharmaceutical Co., Ltd
Phase 2
184
Beijing
2025-04-09
Recruiting
Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma
NCT06995105Advanced Hepatocellular Carcinoma (HCC)
Zhejiang University
Phase 1/2
30
Hangzhou
2025-04-09
By invitation
Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis
NCT06726096Rheumatoid Arthritis (RA), Anti IL-6R
Beijing VDJBio Co., LTD.
Phase 3
615
Beijing
2025-04-09
Recruiting
An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)
NCT06838845Ulcerative Colitis
AbbVie
Observational
80
Guangzhou, Zhengzhou
2025-04-09
Not yet open
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
NCT06926582Psoriasis
Hansoh BioMedical R&D Company
Phase 2
305
Shanghai
2025-04-09
Recruiting
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
NCT05066217Lennox Gastaut Syndrome
Epygenix
Phase 3
260
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Jinan
2025-04-09
Recruiting
Neoadjuvant SNF Precision Therapy Phase III
NCT06913777Neoadjuvant Therapy
Fudan University
Phase 3
404
Shanghai
2025-04-08
Recruiting
Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Glycemic Control and Cardiovascular Disease Risk in Patients With Type 2 Diabetes
NCT06861062Diabetes Mellitus, Type 2
Huazhong University of Science and Technology
Not applicable
2,500
Nanning, Tangshan, Shiyan, Wuhan, Chengdu
2025-04-08
Recruiting
Motor-Cognitive Interactive Upper Limb Robot Rehabilitation for Post-Stroke Motor Dysfunction
NCT06876597Stroke
Lidian Chen
Not applicable
1,047
Fuzhou
2025-04-08
Recruiting
Exploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer
NCT06946615Colorectal Neoplasia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
18
Hangzhou
2025-04-08
Recruiting
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus
NCT06920433Systemic Lupus Erythematosus
Zhejiang University
Phase EARLY_PHASE1
18
Hangzhou
2025-04-08
Recruiting
Linked-Color Imaging Versus Indigo Carmine Pump Spraying on the Colorectal Adenoma Detection Rate
NCT06961149Colonic Polyps, Adenomatous Polyps, Adenoma Detection Rate, Chromoendoscopy
Shandong University
Not applicable
352
Jinan
2025-04-08
Active, closed
A Study to Evaluate the Effect of a High-fat Meal on the Exposure of Pimicotinib Capsule in Healthy Subjects
NCT06884072Healthy Subjects
Abbisko Therapeutics Co, Ltd
Phase 1
16
Changchun
2025-04-08
Recruiting
Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial
NCT06883864Atrial Fibrillation (AF), Catheter Ablation, Atrial Functional Mitral Regurgitation
Beijing Anzhen Hospital
Not applicable
146
Hefei, Beijing, Xiamen, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan
2025-04-08
Active, closed
Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma๏ผˆCSHEIN๏ผ‰
NCT07278674High Risk Neuroblastoma
Shanghai Children's Hospital
Observational
20
Hainan
2025-04-08
Recruiting
ctDNA-MRD Monitoring After Resection in Gastric Cancer
NCT06893133Gastric Cancer
Peking University
Observational
110
Beijing
2025-04-08
Active, closed
BCG for Therapeutic Use Phase โ…ข Clinical Trial
NCT06747455BCG
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Phase 3
439
Shanghai
2025-04-08
Recruiting
Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure
NCT07087223Non Small Cell Lung Cancer NSCLC
Peking University Cancer Hospital & Institute
Phase 1/2
42
Neimeng, Baoding, Baotou, Beijing, Dalian, Tianjin
2025-04-08
Recruiting
Clinical Studies for the Treatment of Advanced Solid Tumors
NCT06825494Advanced Solid Tumor
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1/2
194
Hefei, Beijing, Fuzhou, Lanzhou, Wuwei, Shenzhen, Nanning, Tangshan
2025-04-08
Recruiting
A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients
NCT07010939Breast Neoplasms, Quality of Life (QOL), Toxicities, Breast Diseases
FangYi
Observational
3,000
Beijing, Shenzhen, Taiyuan
2025-04-07
Recruiting
Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer Patients
NCT07162298Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
72
Hangzhou
2025-04-07
Not yet open
A Mass Balance Study of [14C]ABSK011
NCT06896760Healthy Subjects
Abbisko Therapeutics Co, Ltd
Phase 1
6
Beijing
2025-04-07
Recruiting
Evaluation of the Efficacy of Biobran (Rice Bran Arabinoxylan) in Supporting Breast Cancer Chemotherapy
NCT07503496Breast Cancer Stages I, Breast Cancer Stages II, Breast Cancer Stage III
China Medical University Hospital
Not applicable
96
2025-04-07
Recruiting
CAR-NK Cells (CL-NK-001) in Pancreatic Cancer
NCT06816823Pancreatic Cancer
Changhai Hospital
Phase 1
30
Shanghai
2025-04-07
Recruiting
Treatment of Perioperative Neurocognitive Disorders With Olfactory Enrichment
NCT06488807Perioperative Neurocognitive Disorder
Shanghai 10th People's Hospital
Not applicable
686
Shanghai
2025-04-07
Recruiting
A Study of SRSD216 in Patients With Elevated Lipoprotein (a)
NCT07172646Hyperlipoproteinemia (a)
Sirius Therapeutics Co., Ltd.
Phase 1/2
84
Beijing
2025-04-07
Recruiting
Differences in Prosocial Behaviors and Related Brain Networks in Children With Autism and Typical Development
NCT06908174Autism Spectrum Disorder, Healthy
Children's Hospital of Fudan University
Observational
300
Shanghai
2025-04-07
Recruiting
Transcranial Temporal Interference Stimulation In Severely Brain Injured Patients With Disorders of Consciousness
NCT06851156Disorders of Consciousness, Severe Brain Injury, Unresponsive Wakefulness Syndrome, Minimally Conscious State
Xijing Hospital
Not applicable
10
Xi'an
2025-04-07
Recruiting
BC008-1A Injection for Recurrent CNS WHO G4 Glioma
NCT06773481Glioma, Glioma Tumor Recurrence, Glioma, Recurrent High Grade, Glioblastomas (GBM)
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
Phase 1
40
Beijing
2025-04-07
Recruiting
Molecular Subtyping of Breast Cancer-derived Small Extracellular Vesicles (sEVs) to Predict Therapeutic Efficacy
NCT07574749Breast Cancer
Fudan University
Observational
1,500
Shanghai
2025-04-07
Recruiting
A Phase II Clinical Trial of Artificial Intelligence-assisted One-stop Radiotherapy for Breast Cancer After Breast-conserving Surgery
NCT06686459Breast Cancer Invasive
Sun Yat-sen University
Not applicable
860
Guangzhou
2025-04-06
Active, closed
Study on the Pharmacokinetics and Safety of QL1012D and Gonal-Fยฎ in Healthy Female Volunteers
NCT06864793Infertility, Female
Qilu Pharmaceutical Co., Ltd.
Phase 1
48
Changchun
2025-04-06
Recruiting
Adaptive Therapy for Resected Stage โ… A2-โ…ก NSCLC Patients With Undetectable MRD
NCT06924710NSCLC
Peking University Cancer Hospital & Institute
Not applicable
286
Beijing
2025-04-06
Recruiting
The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and Endotyping
NCT06900062Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China
Observational
1,500
Guiyang, Changchun, Jinan, Shanghai, Jiaxing
2025-04-06
Not yet open
Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis
NCT06917495Mild Spinal Tuberculosis
Shandong University
Phase 2
300
Jinan
2025-04-05
Recruiting
Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma
NCT06950827Hepatocellular Carcinoma, Hepatectomy, Laparoscopic Hepatectomy
West China Hospital
Observational
400
Chengdu
2025-04-05
Not yet open
Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC
NCT06916117Locally Advanced Cervical Cancer
RenJi Hospital
Phase 2
30
Shanghai
2025-04-05
Recruiting
Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma
NCT06912074Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University
Phase 2
134
Guangzhou
2025-04-05
Active, closed
Efficacy and Safety of Laparoscopic Lateral Suspension and Transvaginal Sacrospinous Ligament Fixation in Patients With Pelvic Organ Prolapse
NCT06903988Pelvic Organ Prolapse (POP)
Peking University People's Hospital
Not applicable
86
Beijing
2025-04-05
Recruiting
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
NCT06950814Sarcomatoid Carcinoma, Liver Cancer, Adjuvant Therapy
West China Hospital
Observational
50
Chengdu
2025-04-05
Recruiting
Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
NCT06902844Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
Tongji Hospital
Not applicable
6
Wuhan
2025-04-05
Active, closed
Laparoscopic Myomectomy Based on a Fully Enclosed Protective Device: A Novel Surgical Technique Achieving Tumor-Free Protection Throughout the Entire Procedure
NCT07474688Uterine Fibroids (Leiomyoma)
China-Japan Friendship Hospital
Observational
20
Beijing
2025-04-04
Recruiting
A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
NCT06932523Herpes Zoster (HZ)
Shanghai Institute Of Biological Products
Phase 1/2
645
Wuhan
2025-04-04
Recruiting
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
NCT06801834Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Gilead Sciences
Phase 3
695
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin
2025-04-04
Recruiting
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
NCT06828887MDD
Vigonvita Life Sciences
Phase 2
400
Shanghai
2025-04-03
Recruiting
A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
NCT06766357Moderate to Severe Dry Eye
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Phase 3
360
Xiamen
2025-04-03
Recruiting
A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs
NCT06829459Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc.
Phase 3
350
Beijing
2025-04-03
Recruiting
A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants
NCT06889701Periprosthetic Joint Infection (PJI)
TenNor Therapeutics Inc.
Phase 1/2
33
รœrรผmqi
2025-04-03
Active, closed
A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma
NCT07713290Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Cancer
Beijing Gene Key Life Technology Co., Ltd
Phase 1
6
Beijing, Taiyuan
2025-04-03
Active, closed
Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes
NCT06991829Diabetes Mellitus
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
29
Shanghai
2025-04-03
Recruiting
The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial
NCT06946901Hyperthermic Intraperitoneal Chemotherapy, Peritoneal Metastatic Pancreatic Cancer
Shanghai Zhongshan Hospital
Phase 2
90
Changsha, Shanghai
2025-04-03
Recruiting
A Study of BGM0504 in Participants With Obesity
NCT06911203Obesity
BrightGene Bio-Medical Technology Co., Ltd.
Phase 2
90
Beijing
2025-04-03
Recruiting
Evaluation of SYS6005 in Patients With Advanced Malignant Tumor
NCT06958679B-cell Malignancies, Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1
132
Tianjin
2025-04-03
Recruiting
A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia
NCT06841731Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
100
Beijing
2025-04-03
Active, closed
Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection
NCT06934070Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma (HCC) Prognosis
Qiang Xu
Observational
287
Nanchang
2025-04-03
Not yet open
Preemptive Analgesia Of Dexmedetomidine Reduces Per-operation Pain
NCT06671327Pain Management, Noncardiac Surgery
China International Neuroscience Institution
Phase 4
208
Beijing
2025-04-03
Not yet open
7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy
NCT06923254Hepatic Encephalopathy (HE), MRI, fMRI Research
Chinese PLA General Hospital
Observational
200
Beijing
2025-04-03
Recruiting
Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors
NCT06658951HER2-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
Not applicable
30
Zhengzhou
2025-04-03
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
NCT06726148Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
Novartis Pharmaceuticals
Phase 1/2
280
Nanjing, Xian
2025-04-03
Recruiting
SIRT Versus cTACE for Unresectable HCC (CHANCE2506)
NCT06909708Unresectable Hepatocellular Carcinoma
Zhongda Hospital
Not applicable
108
Nanjing
2025-04-03
Recruiting
Phase I Clinical Study of ฮฑ-PD-L1/DLL3 CAR-T in Patients With R/R SCLC
NCT06348797Small Cell Lung Cancer Extensive Stage
Sichuan University
Phase 1
30
Chengdu
2025-04-03
Recruiting
A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
NCT06843889Locally Advanced Esophageal Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University
Phase 2
34
Guangzhou
2025-04-03
Recruiting
Effects of Low-Sodium Salt on Death, HF Hospitalization/ Emergency Department Visits and Quality of Life in HF Patients
NCT06764225Heart Failure, Dietary Sodium Intake
Heart Health Research Center
Not applicable
1,301
Beijing
2025-04-03
Recruiting
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
NCT07348302Rhinitis, Rhinoconjunctivitis
Inmunotek S.L.
Phase 3
736
Beijing, Guangzhou, Zhongshan, Xiangya, Changzhou, Qingdao, Shanghai, Tongji
2025-04-02
By invitation
Clinical Study on Lymphaticovenous Anastomosis๏ผˆLVA๏ผ‰ for the Treatment of Alzheimer's Disease๏ผˆAD๏ผ‰
NCT06918145Alzheimer&Amp;#39;s Disease (AD)
Peking University Third Hospital
Not applicable
80
Beijing
2025-04-02
Recruiting
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
NCT06868732Advanced Non-small Cell Lung Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1
288
Guangzhou
2025-04-02
Recruiting
Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer
NCT07257458Lung Cancer (NSCLC)
Beijing Haidian Hospital
Observational
30
Beijing
2025-04-02
Recruiting
A Clinical Trial of Furmonertinib Combined With Anlotinib as First-line Treatment for Advanced NSCLC With EGFR-sensitive Mutations and Brain Metastasis
NCT06945705NSCLC
Henan Cancer Hospital
Phase 2
146
Zhengzhou
2025-04-02
Recruiting
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
NCT06346600Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics
Observational
83
Hefei, Hangzhou, Wenzhou, Beijing, Shanghai
2025-04-02
Recruiting
A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy
NCT06839066Nasopharyngeal Carcinoma (NPC)
Shanghai Henlius Biotech
Phase 2
70
Fuzhou, Dongguan, Guangzhou, Shenzhen, Nanning, Guiyang, Wuhan, Changsha
2025-04-02
Recruiting
Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5
NCT06901960Chronic Kidney Disease (Stages 3b-5)
Peking University First Hospital
Not applicable
1,066
Beijing, Nanning, Wuhan
2025-04-02
Recruiting
Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus
NCT06946485Systemic Lupus Erythematosus (SLE)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase EARLY_PHASE1
15
Nanjing
2025-04-02
Recruiting
Exploratory Study on the Role of Vitamin C in Promoting Health in Middle-Aged and Elderly Adults
NCT06794255Ageing
Peking University Third Hospital
Not applicable
400
Nanchang, Quzhou, Beijing
2025-04-02
Recruiting
An Engineered Sirpฮฑ Fused to Anti-Pd-L1 And Tgf-ฮฒ Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
NCT06487624Advanced Solid Tumor, Refractory Hodgkin Lymphoma
FBD Biologics Limited
Phase 1
50
Hangzhou, Xuzhou, Yantai, Zhujiang
2025-04-02
Recruiting
A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors
NCT06907628Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
150
Jinan
2025-04-02
Recruiting
Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC
NCT06846450Nasopharyngeal Cancinoma (NPC)
Lin Kong, MD
Phase 3
470
Shanghai
2025-04-01
Recruiting
Using Artificial Intelligence to Improve Radiologists' Performance in Radiology Report Writing: a Randomised Controlled Trial
NCT06907927Healthy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
100
Wuhan
2025-04-01
Recruiting
Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System
NCT07092761Type1diabetes
Henan University of Science and Technology
Not applicable
82
Luoyang
2025-04-01
Active, closed
Acute Myocardial Infarction Clinical Cohort
NCT07522164Acute Myocardial Infarction
Shanghai Zhongshan Hospital
Observational
2,000
Shanghai
2025-04-01
Recruiting
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
NCT06657144Metastatic Solid Tumor, Advanced Solid Tumor
Coherus Oncology, Inc.
Phase 1
154
2025-04-01
Recruiting
Effect of the Home-based Digital-assisted Dyadic Tai Chi (HDTC) Training Program Among Sedentary Individuals With HF and Their Caregivers: a Randomized Controlled Trial
NCT06876441Heart Failure (HF)
The Hong Kong Polytechnic University
Not applicable
256
Qingdao
2025-04-01
Recruiting
Child-Parent Familial Hypercholesterolemia Screening
NCT04529967Familial Hypercholesterolemia
Children's Hospital of Fudan University
Observational
15,000
Hefei, Qidong, Shanghai, Taiyuan, Chongqing, รœrรผmqi
2025-04-01
Recruiting
RIRS With Flex Suction Sheath vs. PCNL for 2-3 cm Renal Stones
NCT07058402Nephrolithiasis
Changhai Hospital
Not applicable
308
Shanghai
2025-04-01
Recruiting
Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden
NCT06867536Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Lymphoma
Liling Zhang
Phase 2
40
Wuhan
2025-04-01
Not yet open
Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.
NCT06888674Pancreatic Cancer Resectable
Zhejiang University
Phase 1/2
60
Hangzhou
2025-04-01
Recruiting
Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.
NCT06894797Locally Advanced Rectal Cancer
Peking University Cancer Hospital & Institute
Not applicable
68
Beijing
2025-04-01
Active, closed
D615L vs Zeiss 839MP: Visual Quality
NCT07571694Cataract
Shanghai 10th People's Hospital
Observational
90
Shanghai
2025-04-01
Recruiting
Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
NCT07353463Parkinson's Disease (PD), Multiple System Atrophy
Ruijin Hospital
Observational
700
Shanghai
2025-04-01
Recruiting
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
NCT06972602Retinoblastoma, Retinoblastoma, Recurrent
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1
10
Shanghai
2025-04-01
Recruiting
Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population
NCT06984510Type 2 Diabetes Mellitus (T2DM), Metabolic Dysfunction-Associated Steatotic Liver Disease, Biological Age
Ningbo No. 1 Hospital
Observational
2,720
Ningbo
2025-04-01
Not yet open
A Single-center Study of CM313 in Patients With Pemphigus
NCT06904040Pemphigus
Sichuan Provincial People's Hospital
Not applicable
20
Chengdu
2025-04-01
Rows per page Showing 8601–8700 of 19052
Previous 85 86 87 88 89 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=87

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.